RBD-BRIDGE™
Partners & Collaborators

Built as a coalition, not a centre

Academic institutions, clinical centres, patient organisations, industry and funders — building one shared architecture together.

Why partner

Small numbers, anywhere — bigger outcomes, together.

No single centre sees enough of a rare bone disease to move the field alone. RBD-IBI is designed to bring partners together on one shared architecture, so scattered expertise can become a common, comparable body of evidence.

  • Contribute to shared imaging biomarker research
  • Shape the common framework and standards as they are built
  • Grow with access to emerging networks, data and expertise
  • Demonstrate commitment to rare bone disease
Start a conversation

Ways to work with us

  • As a research institution — contribute methods, protocols and studies.
  • As a clinical centre — adopt the shared standard and generate comparable data.
  • As a funder or industry partner — enable the infrastructure and translation.
Partners & Collaborators

Building an international RBD imaging-biomarker network.

Named institutions will be listed here once the relevant relationship and permission to display the organisation have been confirmed. For now, we welcome collaboration across these categories:

Interest in RBD-IBI has already been expressed by researchers and clinicians in Australia, Germany and Canada.

Get involved

Would your organisation like to be part of this?

Tell us about your work and we will find a way to connect.